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Clustered Regularly Interspaced Palindromic Repeats (CRISPR) and Cascade 9 (also
known as Cas9, CRISPR associated protein 9) confer protection against invading
viruses or plasmids. The CRISPR/Cascade 9 system constitutes one of the most
powerful genome technologies available to researchers today. So far, this technology
has enabled efficient genome editing and modification in several model organisms
and has successfully been used in biomedicine and biomedical engineering. However,
challenges for efficient and safe genetic manipulation in several organisms persist. Here,
we review functional approaches and future challenges associated with the use of the
CRISPR/Cascade 9 genome editing system and discuss opportunities, ethical issues and
future directions within this field.
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INTRODUCTION
The CRISPR/Cascade 9 system is a RNA-guided system naturally used by archaea and bacteria
for protection/immunity against invading viruses or plasmids and provides an interesting
example of co-evolution between hosts and viruses. The simplicity of the CRISPR/Cascade 9
system has enabled the development of a reliable and efficient genome editing tool which has
revolutionized the ability to manipulate genes in many different organisms (Peng et al., 2014). The
CRISPR/Cascade 9 system comprises three components, small crRNAs (CRISPR RNAs), tracrRNA
(auxiliary trans-activating crRNA), and the CRISPR associated protein 9 (Cascade 9). Cascade 9 is
a RNA guided dsDNA nuclease which together with the crRNA/tracrRNA complex containing the
target sequence of choice, termed the protospacer, is responsible for cleaving the targeted DNA
strand using its HNH and RuvC nuclease domains. Cascade 9 also requires a small sequence
downstream of the hybrid region called PAM (protospacer adjacent motif) that essentially behaves
as a targeting component. The principle of the CRISPR/Cascade 9 system for targeted genome
editing is illustrated in Figure 1. A synthetic fusion between crRNA and tracrRNA harboring
a site-specific 20 bp single guide RNA (sgRNA) is constructed for the desired target site. The
function of promoters directing the synthesis of sgRNAs is modulated by the number of guanidine
residues at the 5′ end of the transcript. A single “G” is present in RNA polymerase III promoters,
whereas two G’s are found in SP6, T3, and T7 promoters. A separate vector drives expression of
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Cascade 9. The site-specific 20-nucleotides sequence of the
sgRNA directs the Cascade 9 nuclease to its target. Double-
strand breaks (DSBs) induced by Cascade 9 are re-ligated by the
error-prone non-homologous end joining (NHEJ) pathway often
resulting in deletions or insertions leading to loss of function
(Figure 2). Structural and functional analyses have demonstrated
that the PAM-binding domain of Cascade 9 interacts with
the non-complementary strand GG dinucleotide via conserved
arginine residues in the carboxy-terminal domain of Cascade
9, suggesting possibilities for overcoming the PAM-dependent
limitation of targetable sequences (Anders et al., 2014).
Accordingly, engineered SpCascade 9 and SaCascade 9 have
recently been developed by utilizing bacterial selection-based
directed evolution to recognize alternative PAMs (Kleinstiver
et al., 2015). The SpCascade 9-VQR and SpCascade 9-EQR
variants primarily recognize 5′-NGAN-3′ and 5′-NGNG-3′
PAMs, while the SpCascade 9-VRER variant is specific for the
5′-NGCG-3′ PMA motif, and using a structure-guided design
strategy FnCascade 9 has been modified to recognize YG PAM
sequences rather than NGG (Hirano et al., 2016).
Due to the simplicity and effectiveness of the CRISPR/Cascade
9 system, it is currently extensively used for genome editing
in different organisms. Unlike protocols based on zinc-
finger nucleases (ZNFs) and transcription activator-like effector
nucleases (TALENs), protein engineering is not required, and it
is possible to use sgRNAs targeting multiple sites. However, it
should be noted that off-target modifications can be observed.
The extent to which such off-target events occur seems to be
correlated with the size and complexity of the targeted genome
(Wei et al., 2014). Thus, reflecting genome sizes off-target
events are more likely to occur in monocotyledonous plants
than in dicotyledonous plants, and in vertebrates compared
to invertebrates (Gregory et al., 2007) (Li and Du, 2014). In
principle, the CRISPR/Cascade 9 system enables genome editing
in embryos which, however, still is controversial. Furthermore,
a number of technical issues still remain to be addressed
(Chrenek et al., 2016), and specific deign for effective genome
editing in embryos of different organisms may be required.
For instance, the choice of delivery of the CRISPR/Cascade 9
system, electroporation, microinjection, and vector types used
in vitro and in vivo remains challenging. In addition, toxicity of
vectors and other components of CRISPR/Cascade 9 system also
constitutes a challenge and needs to be addressed (Bassett et al.,
2013). However, the successful correction of a gene in 42 out of
58 human embryos was recently reported (Ma et al., 2017).
Conventional gene disruption approaches such as gene
deletion, gene insertion or frame-shift in coding sequences are all
expensive and labor-intensive due to the inefficient homologous
recombination-based protocols (Cong et al., 2013), and the use of
alternative protocols using meganucleases has been limited due
to the complex mechanism of genome editing associated with
this approach (Silva et al., 2011). By contrast, already now the
CRISPR/Cascade 9 system has been used for genome editing in a
large variety of species as summarized in Table 1. Here we review
different approaches and challenges associated with the use of the
CRISPR/Cascade 9 system and discuss opportunities and future
directions including ethical concerns.
GENE DISRUPTION APPROACHES IN
ORGANISMS
Knockout Approaches
The use of the CRISPR/Cascade 9 system technology is
rapidly increasing using different model systems and has
allowed effective whole-genome screening for identification of
therapeutic targets (see Table 1). Candidate gene knockout is
a powerful approach as it may directly identify a phenotype
resulting from the loss-of-function of the targeted gene. The
CRISPR/Cascade 9-mediated knockout technology has been used
in different genetic model organisms, including insects (Liu Y.
et al., 2014; Xue et al., 2014), Caenorhabditis elegans (Liu P.
et al., 2014) and humans (Tsai et al., 2014). Highly efficient
mutagenesis of the yellow gene was achieved by injecting a
sgRNA targeting an exon of the gene in Drosophila embryos
(Bassett et al., 2013). As an example to illustrate the power of
the CRISPR/Cascade 9 system, successful targeting of 14 distinct
genomic loci in Arabidopsis with no detectable off-target events
has been reported, also pointing to the CRISPR/Cascade 9 system
as a powerful tool for agricultural purposes (Peterson et al., 2016).
Novel approaches for base-editing technology are essential
for improving the efficiency of gene knockout or silencing. The
recently developed WT-Cascade 9 -mediated gene knockout and
CRISPR-STOP approaches, termed second generation genome
editing tools, represent such two novel developments. The WT-
Cascade 9 approach, which creates DSBs and indels at the target
sites, allows exchange of a single specific base using the nickase
activity of Cascade 9 to introduce C to T or A to G conversions
at the specific target site (Gaudelli et al., 2017) (Komor et al.,
2016). The CRISPR-STOP approach enables the insertion of early
STOP codons in genes (Kuscu et al., 2017) with the codons CGA
(Arg), CAG (Gln), and CAA (Gln) being effectively converted
into stop codons with higher efficiency using the CRISPR-
STOP approach than the WT-Cascade 9 knockout approach
(Billon et al., 2017). Recently, Zuo et al. reported on a one–
step generation of complete knockout of several genes in mouse
and monkey models using multiple sgRN spaced 10–200 bp
apart targeting a single key exon in each target gene. Phenotypic
analysis of first generation mice revealed specific deletion of eight
genes on the Y chromosome. This approach also resulted in
highly-efficient gene knockout in monkeys (Zuo et al., 2017).
Successful multiple gene knockout was further achieved by using
a combination of dual sgRNAs in C. elegans where multiple
sgRNA sequences were incorporated into a single CRISPR
systems enabling selective editing and reducing off-target effect
(Chen et al., 2015). Finally, in utero electroporation represents
an interesting option for organ-specific gene knockout using the
CRISPR/Cascade 9 system. As an example, Shinmyo et al. (2016)
reported on a highly effective knockout of the Satb2 gene in the
mouse (Shinmyo et al., 2016).
Knock-In Approaches
Gene knock-in in different model organisms has traditionally
been based on homologous recombination (HR) and NHEJ.
Knock-in based on NHEJ has to some extent reduced time-
consuming labor and has improved gene knock-in in cells and
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FIGURE 1 | Schematic illustration of the CRISPR/Cascade 9 system and the genome editing process. (A) sgRNA is designed to target the genome with the standard
sequence of 5′-GG(G/A)-N17/18-NGG-3′ at the 5′ of a PAM (NGG). (B) Map of the pSP6-2sNLS-SpCas9 vector. (C) Map of the pMD19-T sgRNA scaffold vector
used to produce sgRNA driven by the T7 promoter.
FIGURE 2 | The basic working principle of the sgRNA-editing technology. Double strand break (DSB) repair can be used to target defined genomic modification. The
double strand break (DSB) induced by the Cascade 9/sgRNA complex can be repaired through non-homologous end joining (NHEJ) or homologous recombination
(HR). This can result in short insertions or deletions at the target site (left), deletions of larger genomic regions when two cuts are made (middle) or homologous repair
with a desired template (brown). This can be used to alter the genome in a variety of different ways (bottom).
animals with low HR frequency (Yoshimi et al., 2016). However,
double-strand DNA breaks (DSB) initiated by Cascade 9 are
preferentially repaired by NHEJ, which is not appropriate for
knocking-in genes. DSBs may also increase homology-directed
repair (HDR)-dependent gene editing and knock-in, but several
studies have recently shown that HDR-mediated gene knock-in
in zebra fish (Auer et al., 2014; Irion et al., 2014) and Xenopus
(Shi et al., 2015) was ineffective using the CRISPR/Cascade
9 system. Although the molecular mechanisms underlying
DSB-induced mutagenesis have been intensely investigated, a
number of questions remains concerning the use of homologous
and micro-homologous sequences during template change
in synthesis-dependent strand annealing (SDSA) and break-
induced replication (BIR). Thus, it remains to be established
to what extent the molecular mechanisms of SDSA and BIR
have been maintained in different eukaryotes with different
genome size or structure. A few studies using human cells
have demonstrated that CRISPR/Cascade 9-NHEJ may result
in effective DNA insertion and that the knock-in efficiency
was improved compared with a HDR-based approach (He
et al., 2016). Still, in a lung cancer mouse model, efficient
knock-in of the KRAS, p53, and LKB1 genes by CRISPR-based
HDR has offered the ability to create defined modifications in
genetic sequences associated with cancer (Platt et al., 2014).
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Interestingly, suppressing the NHEJ pathway or increasing the
HDR pathway has been shown to enhance nuclease-mediated
knock-in efficiency both in vitro and in vivo, and studies have
further shown that small molecules such as Scr7, L755507 and
resveratrol may enhance HDR-dependent knock-in efficiency of
the CRISPR/Cascade 9 system. Thus, the supplementation with
such small molecules may also be advantageous for production
of genetically modified animals (Li et al., 2017). It should
be mentioned that Suzuki and coworkers recently designed a
micro-homology-mediated end joining (MMEJ)-assisted knock-
in approach and a CRISPR-MMEJ-mediated tagging approach
that have been applied in a variety of settings, ranging from cell
lines such as HEK293T, HeLa, CHO-K1 to silkworm, zebrafish
and frog (Sakuma et al., 2016). This vector delivery approach
is efficient for gene editing, reaching 85% efficiency (Xiong
et al., 2017). Finally, a recently described CRISPR-mediated
epitope tagging approach holds promises for efficient gene
knock-in (Nitika and Truman, 2017). So far, NHEJ-mediated
repair of CRISPR/Cascade 9-mediated insertion of large DNA
fragments has not been investigated in humans, and effective
knock-in in human embryonic stem cell (ESCs) still constitutes
a challenge. Experiments in model organisms that combine
next-generation sequencing and genomic studies are clearly
warranted to address remining problems associated with the
use of the CRISPR/Cascade 9 system (Rodgers and McVey,
2016).
Conditional Approaches
Conditional knock-out (cKO) models circumvent a number
of the problems related to the use of constitutive knock-out
models such as embryonic lethality. cKO methods have been
used widely for achieving tissue-specific gene deletion in the
mouse (Kühn et al., 1995) and in the zebrafish. cKO models
may further aid investigation and understanding of a number of
human diseases. Conditional mutant models are thus becoming
indispensable tools in the biomedical field (Rosenthal and Brown,
2007). Conditional approaches can overcome the limitations
faced by simple knockout strategies using the CRISPR/Cascade
9 system for studies on embryogenesis as they allow temporal
targeting of a specific tissue/organ at determined developmental
stages and enable cell lineage tracing. As illustrated in Figure 3A,
using the DNA sequence 5′-GG(G/A)-N17/18-NGG-3′ at the
5′ of a PAM (NGG) and designed Oligo-L and Oligo-R
(Figure 3B), a specific gene exon can be targeted by two
sgRNA following microinjected of Cascade 9 and the sgRNAs
(Figures 3C,D). It has been demonstrated that the fusion of
a FKBP12-derived destabilizing domain to Cascade 9 alters
conditional Cascade 9 expression and the temporal control of
gene editing in the presence of an FKBP12 synthetic ligand
allowing investigation of the interactions between functional
genes (Figure 4). In conclusion, the CRISPR/Cascade 9 system
has successfully been used to generate conditional knock-out
mice, rats and C. elegans (Ma et al., 2014), demonstrating that
the CRISPR/Cascade 9 is a powerful tool for investigating the
relationship between genotype and phenotype in developmental
biology.
Gene Correction Approaches
Targeted gene correction may eventually be used for disease
therapy including diseases such as muscular dystrophy, cystic
fibrosis, hemophilia A and B, and Gauche disease. Previously,
the cost of treatment, safety, and efficacy of gene editing has
constituted huge obstacles, but some of these difficulties have
now been circumvented by the development of CRISPR/Cascade
9 gene editing. For instance, Song et al. have successfully
corrected mutations causing beta-thalassemia using iPSCs in
combination with CRISPR/Cascade 9 without any observed off-
target effects (Song et al., 2015). Further, the Cpf1 protein, a
type V CRISPR effector, has been successfully used to induce
mutations in the soybean genome (Fagerlund et al., 2015). Gene
insertions or deletions can be introduced in cancerous cell
using CRISPR/Cascade 9 technology. Thus, the CRISPR/Cascade
9 system may be used for insertion of inactivating indels
in the oncogenic receptor tyrosine kinase Erb2, and the
CRISPR/Cascade 9 technology has been applied in connection
with lung cancer models and diseases including tyrosinemia
and amyotrophic lateral sclerosis (Wang et al., 2017b; Yin
et al., 2017b). In recent years, Mycoplasma and Escherichia
coli genes have been edited in vivo in yeast cells using the
CRISPR/Cascade 9 system (Tsarmpopoulos et al., 2016) and
established standardized sequences of S. cerevisiae genes (selected
from overexpression or gene knockdown) have been integrated
into the yeast genome using the CRISPR/Cascade 9 system
(Giersch and Finnigan, 2017). In the future, sgRNA may provide
even better options for editing endogenous genomic sites and
perform functional analysis of genes.
Gene correction approaches can be categorized into four
types (1) endogenous gene disruption, (2) frame-shift to restore
protein reading frame, (3) foreign sequence insertion using
target-specific knock-in, and (4) mutated sequence substitution
(Figure 5) (Lisa Li et al., 2014; Yin et al., 2017a). According to the
Online Mendelian Inheritance in Man (OMIM) database, more
than 8,000 inherited monogenic diseases arising from mutations
in a single gene have been identified. However, an efficient
drug therapy does not exist for the majority of these diseases.
Therefore, gene therapy approaches by correcting the mutated
loci using the CRISPR/Cascade 9 system represents a potential
powerful tool for treatment. Yet increasing the efficiency of gene
correction would be required for use in the biomedical field and
off-target effects are of concern in relation to safety and side
effects and this raises numerous questions in relation to ethics
and safety (Yin H. et al., 2015).
GENE KNOCK-DOWN AND SILENCING
APPROACHES
The CRISPR/Cascade 9 technology has revolutionized molecular
genetics and the technology may eventually be extensively used
for gene functional studies. The efficiency of gene knock-down
using the CRISPR/Cascade 9 system varies in relation to length
and complementary to the crRNA sequence and the particular
location of the gene (Gilbert et al., 2013). In the laboratory, the
researchers face the choice between cutting-edge technologies
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TABLE 1 | Examples of CRISPR/ Cascade 9-mediated genome editing in human cells and model organisms.
Different approaches Organisms Genes References
Gene knockout INVERTERBRATES
Drosophila Yellow, white, AGO1 Bassett et al., 2013, 2014
Silkworm BmWnt1, BmBLOS2
Bm-ok, BmKMO, BmTH, and Bmtan Wang et al., 2013; Zhang et al., 2015
Wei et al., 2014
Caenorhabditis elegans csr-1, mes-6, dpy-3, unc-1 Cho et al., 2013b; Chen et al., 2015
Yeast ADE2 Giersch and Finnigan, 2017
VERTEBRATES
Human H69, DMRT1, DMRT3, NF1, MED12,
NF2, CUL3, TADA2B, TADA1, MAGEC2,
S100A4, OCIAD1
Shalem et al., 2014; Shetty and Inamdar,
2016; Tahara et al., 2016; Wang et al.,
2016; Inui et al., 2017; Wills et al., 2017
Zebrafish cyp19a1a, valopa, valopb Hang et al., 2016; Lau et al., 2016
Mouse Rp9 Lv et al., 2017
Chicken Stra8, Myostatin Lee et al., 2017; Zhang et al., 2017
Monkey Ppar-γ , Rag1 Niu et al., 2014
PLANTS
Arabidopsis Tobacco Sorghum and Rice OsSWEET14 and OsSWEET11, PDS3,
TTG1, IAA2, CDK
Jiang et al., 2013; Endo et al., 2015;
Ryder et al., 2017; Tsutsui and
Higashiyama, 2017
Gene knock-in INVERTERBRATES
Drosophila nanos, yellow locus, white locus Xue et al., 2014; Port et al., 2015
Silkworm Bmku70 Ma et al., 2015
Caenorhabditis elegans unc-119 Zhao et al., 2014
VERTERBRATES
Human DACT1, IFIT1and EGR1 Zhang et al., 2006
Zebrafish zebrafish th, tardbp, fus Armstrong et al., 2016
Mouse Rosa26, KRAS, p53,LKB1 Li et al., 2015
Chicken yRad52 Platt et al., 2014; Chu et al., 2016
Pig COL1A Park et al., 2016; Wang et al., 2017a
PLANTS
Arabidopsis PDS3, AtFLS2 Li et al., 2014
Tobacco No
Rice WDV Wang et al., 2017
Gene Knockdown and
silencing approaches
INVERTERBRATES
Drosophila roX1, roX2, Ghosh et al., 2016
Caenorhabditis elegans TRHR-1
Silkworm No Van Sinay et al., 2017
VERTERBRATES
Human Zebrafish Mouse Chicken Pig EPHA1
mmp21
Nrl
No
No
Cui et al., 2017
Guimier et al., 2015
Yu et al., 2017
Gene correction INVERTERBRATES
Drosophila No
Caenorhabditis elegans No
Silkworm No
VERTERBRATES
Human MYBPC3 Ma et al., 2017
Zebrafish No
Mouse Hemophilia B, Pde6b
Chicken No Huai et al., 2017
Pig No
(Continued)
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TABLE 1 | Continued
Different approaches Organisms Genes References
Conditional
approaches
INVERTERBRATES
Drosophila bam, nos, cid, ms(3)k81, wg Port et al., 2014; Xue et al., 2014
Caenorhabditis elegans dpy-5, lon-2, unc-76
Silkworm No Shen et al., 2014
VERTERBRATES
Human puroR, Ctnnb1 Shen et al., 2014
Zebrafish tyr, insra; insrb, ascl1a
Mouse Mecp2, Ispd, Kras; p53;
Lkb 1
Yin L. et al., 2015
Chicken No Yang et al., 2013; Lee and Lloyd, 2014;
Platt et al., 2014
Pig PFFs Liu et al., 2016
FIGURE 3 | Scheme illustrating the sgRNA structure and mechanism of the target recognition. (A) The target DNA sequence is 5′-GG(G/A)-N17/18-NGG-3′ at the 5′
of a PAM (NGG). (B) Gene Oligo-L and Gen Oligo-R were deigned. (C) Gene exon was targeted by two sgRNA. (D) Cascade 9 and sgRNAs were microinjected into
the organism.
and more established methods of RNA interference (RNAi)-
mediated knock-down (Chang et al., 2016). Small interference
RNA (siRNA), plasmid and virus-encoded short hairpin RNA
are used in well-established procedures to knock-down target
genes post-transcriptionally. By binding to the target mRNA, a
siRNA will decrease stability and translation. The siRNA can
be synthesized from a vector encoding a shRNA, an artificial
RNA molecule containing a hairpin that is processed into
the mature siRNA by the recipient cell enabling large-scale
gene knockdown screening (Wang et al., 2016). Similarly, by
producing a library of sgRNA targeting specific gene coding
regions, the CRISPR/Cascade 9 systems can be used to screen
for genes involved in molecular network. Recently, it was
shown that Cas13a from Leptotrichia wadei enables targeted
knock-down of RNA transcripts in bacteria, plant cells, and
mammalian cells with an efficiency similar to that obtained by
RNA interference, but with higher specificity. This approach can
be applied for genome-wide knockdown screening, interrogation
of lncRNA and nascent transcript function, including allele-
specific knockdown, and RNA viral therapeutics (Abudayyeh
et al., 2017)
The CRISPR/Cascade 9 system using catalytically inactive
Cascade 9 is able to deliver 46–63% gene silencing in HEK293
cells and exhibits even higher efficiency in E. coli (Qi et al.,
2013). Although studies using CRISPR/Cascade 9 technology for
complete gene knock-out may reveal more clear phenotypes and
less false readouts compared with the variable knock-down of
expression using RNAi, the efficiency of the CRISPR/Cascade 9
system is limited by the delivery of Cas9 and synthesis of guide
RNA (gRNA) and further improvement is still needed.
OFF-TARGET EFFECTS
Off-target effects represent one of the major challenges as
Cascade 9 may recognize sequences with up to 5 mismatched
bases. This means that off-target effects may occur to a higher rate
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FIGURE 4 | Schematic illustration of the principle behind generation of a conditional allele. A gene exon was targeted by two sgRNAs (sgRNA-L and sgRNA-R) which
were designed to cut both ends of the gene exon, A single ssOD was designed to carry the two FRT sequences. All constructs and cascade 9 were microinjected into
the organism.
FIGURE 5 | Overview of potential genome engineering outcomes using site-specific nucleases. (Left) Nuclease-induced DNA double-strand breaks (DSBs) can be
repaired by homologous recombination (HR) or error-prone non-homologous end joining (NHEJ). In the absence of donor plasmid, NHEJ-mediated repair yields short
insertion or deletion mutations at the target that cause gene disruption. DNA fragments up to 14 kb have been inserted via NHEJ-mediated ligation. Simultaneous
induction of two DSBs can lead to deletions, inversions and translocations of the intervening segment (A). Gene disruption by short insertion or deletion (B). Gene
deletion (C). Gene inversion (D). Gene insertion (Right) In the presence of a donor plasmid with extended homology, HR can lead to the introduction of single or
multiple transgenes to correct or replace existing genes (E). Gene addition (F). Gene addition.
than observed using other methods for genome editing. Some
approaches to understand and overcome this limitation exist.
Recent studies have revealed that DNA-RNA chimeric guides
may provide a new strategy to reduce cost and off-target effects
in human cells. Cpf1, a single RNA endonuclease utilizes a T-
rich PAM on the 5′ side of the guide (Zetsche et al., 2016). Cpf1
originates from Acidaminococcus sp and a Cpf1-crRNA with an
eight nucleotides DNA replacement at the 3′ end was produced.
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HEK293T cells were transfected with a plasmid expressing the
Cpf1 protein followed by crRNAs after 24 h. This experiment
showed that the Cpf1 crRNA with partial DNA replacement
reduced off target effect in human cells (Yin et al., 2018).
Novel ways to increase the targeting specificity and reduced off-
target effects are actively pursued. Thus, it was reported that
specific point mutations increased the specificity of SpCascade
9 (Kleinstiver et al., 2016). Similarly, CRISPR structure-guided
rational designs have resulted in Cascade 9 variants with
increased targeting specificity (Hsu et al., 2013). Studies aimed
to re-engineer the Cascade 9 structure and alternative targeting
approaches to reduce off-target effects are on-going. These efforts
include deep sequencing of single targeted sequences in the
genome to detect off-target loci, modification of guide RNA and
Cascade 9 (Cho et al., 2013a) as well as correcting off-target
mutations by back crossing to the wild-type (Bassett and Liu,
2014). Further, studies have shown that nick Cascade 9 can
improve the specificity of target recognition in mammalian cell
(Fujii et al., 2014) and a double-nicking strategy can reduce off-
target effects of Cascade 9 (Ran et al., 2014). Finally, one study
reported that paired Cascade 9 nickases, composed of D10A
Cascade 9 and guide RNA, which produce two single-strand
breaks (SSBs) or nicks in the DNA strands, were highly specific
in human cells, avoiding off-target mutations without sacrificing
genome-editing efficiency demonstrating that such strategy could
be effective for genome editing without significant off-target
effects (Cho et al., 2014).
In conclusion, reducing off-target effects may expand the
applications of this gene-editing technology (Kleinstiver et al.,
2016). To achieve this goal, more studies to understand
the off-target mechanism and better design of sgRNA are
important and deep sequencing analysis or high-throughput
sequencing of numerous sgRNAs may provide important
information regarding potential off-targets associated with the
CRISPR/Cascade 9 system.
CONCLUSIONS AND PERSPECTIVES
Despite the success achieved by the use of ZFNs, TALENs, and
the RNA-guided Cascade 9 system, important challenges related
to the effectiveness, specificity, and safety of the CRISPR/Cascade
9 system remain. In addition, the optimal RNA scaffold of
CRISPR/Cascade 9 for application in several eukaryotic systems
is not known. It also remains to comprehensively evaluate
off-targets of Cascade 9 nucleases in the genome of interest.
In this context, construction of novel versions of Cascade 9
or sgRNAs/crRNAs may improve the on- and off-target ratio.
A system identified in the bacterium Neisseria meningitides
and uses a longer recognition sequence was recently described
(Zhang et al., 2013). Finally, it has been suggested that
lower concentrations of CRISPR/Cascade 9 reagents in cell
diminished cleaving at off-target sites compared to cleaving
at on-target sites (Pattanayak et al., 2013). To transform
the future of genetic biology, an in-depth analysis of ZFN,
TALENs, or CRISPR/Cascade 9 systems based on visualization,
detection and purification of protein is needed, but so far
the CRISPR/Cascade 9 system seems to be the system of
choice. Thus, detailed studies of gene function by using the
CRISPR/Cascade 9 system have provided novel insight indicating
that the CRISPR/Cascade 9 system has the potential to become
the key genome editing tool in modern biology (Table 1).
However, further investigations into the CRISPR/Cascade 9
system are clearly required to determine its effectiveness in
generating a versatile and heritable modification of target
genes, specifically in animals and plants, and more knowledge
clearly is needed, and optimization for different cell types and
organisms will be required prior to therapeutically and clinical
applications.
During transfection or micro-injection with standard viral
vectors some cells or tissues could be refractory. Hence, it is
a challenge to develop methods securing specific and effective
expression of the Cascade 9 nuclease and/or the sgRNAs for
each cell type or developmental stage. Additionally, ensuring
that a single vector efficiently expresses numerous gRNAs
would expand the use of the CRISPR/Cascade 9 systems.
Altogether, such improvements would be very important in
relation to research and therapeutic applications. Improving
methods to specifically change the structure or function of a
given gene will allow reverse genetics approaches for any cell
type or organism of interest. Still, the levels of Cascade 9 off-
target effects remain a problem and the attempts to improve
specificity are of importance. The recently developed catalytically
dead Cascade 9 (dCas9) 9-targeted somatic hypermutation (a
strategy known as CRISPR-X) technology for protein engineering
enables specific mutation of endogenous targets with limited off-
target damage and is a potentially powerful new approach to
investigate the relationship between drug and protein (Hess et al.,
2016).
The CRISPR/Cascade 9 technique was recently used to
remove porcine endogenous retroviruses (PERVs) from the
porcine genome, an achievement of importance in relation to
future organ transplantation from pigs to human. However,
more work regarding safety of cross-species viral transmission
is required (Niu et al., 2017). One interesting CRISPR
application relates to “gene drive” that can target whole
population or a species. Here it has been demonstrated that
a gene allele that confers a parasite-resistant phenotype in
mosquitos can rapidly spread into the population in a non-
Mendelian fashion (Gantz et al., 2015; Hammond et al.,
2016).
Genome editing technology has emerged as a promising
field in relation to medical applications, but guidelines for
designing preclinical trials studies and ethical issues surrounding
genome editing and genomic analysis at a population level
remain to be established. Thus, the ethical issues regarding
the application of the CRISPR/Cascade 9 system in relation
to gene therapy are huge (Cyranoski, 2015; Lanphier et al.,
2015; Ma et al., 2017). Ethical issues comprise problems of
safety, setups in clinical trials, and the criteria for including
patients for research and treatment. Key ethical questions in
relation to gene therapy in clinical trials also include decisions
on criteria for when to implement a new concept in gene therapy
where the long term consequences are unknown. Such ethical
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issues are of paramount importance and the involvement of
and accept from the public before instigating such radical novel
modalities for treatment of human diseases represent a genuine
challenge.
Since the development of the CRISPR/Cascade 9 system,
novel opportunities in the field of biomedical research have
emerged. However, the effectiveness, accuracy, resolution, and
genetic mutation variation still depend on several factors
including sgRNA design, DSB introduced, and quantity of
nuclease. The safety of the Cascade 9 system for introduction of
heritable modifications of specific genes in plants and animals
remains to be fully elucidated. Especially, the off-target effects
of this system remain to be determined on a large genome-
wide scale. Attention clearly needs to be devoted to future
applications such as gene therapy and drug screening in the
medical field. While the CRISPR/Cascade 9 technology has
proven its applicability within numerous lines of basic research,
ethical issues as discussed above are needed to be addressed
and internationally accepted guidelines need to be adopted
for the further use of this technology for genome editing in
humans.
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